Each cell in your body relies on precise communication with other cells to function properly. At the center of this process ...
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® ...
Abalone Bio, an antibody company measuring large-scale activity data to drive AI-powered discovery of active therapeutics, ...
12d
News Medical on MSNUnderstanding the role of astrocytic G protein-coupled receptors in substance-use disordersA recent study published in Engineering delves into the complex mechanisms of drug addiction, highlighting the crucial role of astrocytic G protein-coupled receptors (GPCRs).
3d
Pharmaceutical Technology on MSNBoehringer Ingelheim and Salipro enter drug discovery partnershipThe partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
G protein-coupled receptors (GPCRs) are integral membrane proteins with seven membrane-spanning helices. Upon binding to a ligand – which can range from small molecules like cyclic AMP to ...
4d
News Medical on MSNHow gut health shapes heart disease risk — and what you can do about itA new review highlights how gut microbiome imbalances contribute to cardiovascular disease by altering short-chain fatty ...
Researchers at Monash University have uncovered how the gut—and the food we eat—affects high blood pressure. Their discovery ...
Cambridge, UK-based biotech start-up Maxion Therapeutics, which is developing antibody-based KnotBody drugs for ion channel- ...
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with Boehringer Ingelheim to accelerate ...
News Medical on MSN9d
NIH-Funded Research Team Engineers New Drug Targeting Pain Sensation Pathway with Implications for Chronic Pain TreatmentNIH-Funded Research Team Engineers New Drug Targeting Pain Sensation Pathway with Implications for Chronic Pain Treatment ...
Endocannabinoids are lipid mediators that interact with G protein-coupled receptors, including cannabinoid CB2 receptor (CB2R), which is mainly expressed in peripheral tissues with immune functions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results